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Abstract
Background: Finding a material that supports bone regeneration is the concern for many investigators. We
supposed that a composite scaffold of poly(ε) caprolactone and β-tricalcium phosphate (PCL-TCP) would entail
desirable characteristics of biocompatibility, bioresorbability, rigidity, and osteoconductivity for a proper guided
bone regeneration. Furthermore, the incorporation of mesenchymal stem cells (MSCs) and platelet-rich plasma
(PRP) would boost the bone regeneration. We conducted this study to evaluate the bone regeneration capacity of
PCL-TCP scaffold that is loaded with MSCs and PRP.
Materials and methods: Five miniature pigs received 6 implants in 6 created-mandibular bony defects in the right
and left lower premolar areas. The bony defects were managed according to the following three groups: the PCL-
TCP scaffold loaded with MSCs and PRP (MSCs+PRP+PCL-TCP) group (n = 10), PCL-TCP scaffold loaded with PRP
(PRP+PCL-TCP) group (n = 10), and PCL-TCP scaffold group (n = 10). After 12 weeks, the bone regeneration was
assessed using fluorochrome bone labeling, μCT bone morphogenic analysis, and histomorphometric analysis.
Results: All of the three groups supported the bone regeneration around the dental implants. However, the PCL-
TCP scaffold loaded with MSCs and PRP (MSCs+PRP+PCL-TCP) group showed non-significant higher bone surface,
bone specific surface, and bone surface density than the other two groups as revealed by the μCT bone
morphogenic analysis. Histologically, the same group revealed higher bone-implant contact ratio (BIC) (p = 0.017)
and new bone height formation (NBH, mm) (p = 0.0097) with statistically significant difference compared to the
PCL-TCP scaffold group.
Conclusions: PCL-TCP scaffold is compatible for bone regeneration in bone defects surrounding dental implants.
Moreover, the incorporation of MSCs and PRP optimized the bone regeneration process with respect to the rate of
scaffold replacement, the height of the regenerated bone, and implant stability.
Keywords: Mesenchymal stem cells, Platelet-rich plasma, Polycaprolactone, β-Tricalcium phosphate, Guided bone
regeneration, Dental implants
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Background
Achieving proper dental implant stability and survivabil-
ity has been challenged by the deficiency of the hosting
alveolar bone in respect to height, width, and well-
maintained bony walls [1]. Autologous bone graft has
been the standard approach to reconstruct the alveolar
bony defects due to its osseoinductive, osseoconductive,
and osteogenic properties. Nevertheless, the high resorp-
tion rate of the autologous bone grafts, which could
reach 60%, may jeopardize the clinical outcomes [2].
Moreover, the autologous bone graft might be associated
with donor site morbidity such as, infection, pain, blood
loss, and scarring [3].
Recently, guided bone regeneration has grown im-
mensely. This procedure includes the application of a
membrane to exclude non-osteogenic tissue from inter-
fering with bone regeneration. This membrane can be
resorbable or non-resorbable and it should have some
essential properties like biocompatibility, clinical man-
ageability, and space making ability [4]. Polycaprolactone
(PCL)-based scaffolds are characterized by biocompati-
bility, bioresorbability, and manageability. However, they
lack rigidity, stability, and osteoconductive capacity [5].
The incorporation of β-tricalcium phosphate (TCP) had
enhanced the rigidity and osteoconductivity of PCL
based scaffolds [6]. In terms of bone regeneration, mes-
enchymal stem cells (MSCs) and platelet-rich plasma
(PRP) have been reported to boost the bone formation
through promoting the osteoblasts formation and
vascularization [7–9]. Accordingly, we conducted this
study to evaluate the bone regeneration capacity of PCL-




The animal studies were performed after receiving ap-
proval of the Institutional Animal Care and Use Com-
mittee (IACUC) in Seoul National University. Five male
miniature pigs (SPF Micropig®, PWG Genetics Korea,
Ltd., Korea), aged 12.5 to 17.5 months (32.8 to 41.0 kg
in weight), were used in this study. Each miniature pig
received 6 implants; 3 implants on each side of the infer-
ior bone of the mandible at the premolar area. Buccal
bony defects were created after the implant site prepar-
ation and before the implants placement. A total of 30
buccal bone defects were equally distributed to 10 bony
defects for each of the designed three groups (2 out of 6
defects assigned for each of the three groups in each
animal):
 MSCs+PRP+PCL-TCP group. Mesenchymal stem
cells and platelet-rich plasma loaded into polycapro-
lactone - β-tricalcium phosphate scaffold (n = 10)
 PRP+PCL-TCP group. Platelet-rich plasma loaded
into polycaprolactone-β-tricalcium phosphate scaf-
fold (n = 10)
 PCL-TCP group. Polycaprolactone-β-tricalcium
phosphate scaffold (n = 10)
PCL-TCP scaffold fabrication
A composite scaffold of PCL-TCP (80:20%) (Osteopore
International Pte. Ltd., Singapore) was fabricated using
the fused deposition modeling method that was de-
scribed in previous reports [10, 11]. The scaffold was de-
signed as honeycomb structure with 0°, 60°, and 120°
cross linking; 70% porosity and 0.515 mm average pore
size. The scaffold was cut into a half-tube shape with 4-
mm inner diameter, 8-mm outer diameter, and 2-mm
thickness. This dimension was selected to allow the scaf-
fold to fit around the dental implants promptly (Fig. 1).
Human umbilical cord derived mesenchymal stem cells
(hUCMSCs)
The cells were obtained from the Research Institute of
Biotechnology at Dongguk University, Korea. The cells
were found positive against CD 73, CD 90, CD 105, and
CD 166 markers and negative against CD14, CD 31, and
CD 45 markers using fluorescence activated cell sorting
(FACS) analysis. The cells differentiation abilities were
proved by inducing the cells to differentiate into osteo-
cytes, chondrocytes, and adipocytes.
The cells were seeded and expanded using low glucose
Dulbecco’s modified Eagle’s medium (LG-DMEM;
Gibco-BRL, USA) containing 10% fetal bovine serum
(FBS; Gibco-BRL, USA) and 1% penicillin/streptomycin
(PAA laboratories, Germany). Cells medium was chan-
ged every 3 days. The cells were harvested at 80% con-
fluency and 5 passages and then loaded into the scaffold
of MSCs+PRP+PCL-TCP group with cell density of 4 ×
107 cells/ml at the day of implantation using a
micropipette.
Platelet-rich plasma (PRP) preparation
PRP preparation and loading took place on the day of
operation at the time of the dental implants sites prepar-
ation. A total of 200 ml of blood was aspirated and di-
vided into 4 tubes with 50 ml per each. The tubes were
already coated with 0.2 gm EDTA as anticoagulant. The
PRP preparation conducted in two-steps. The blood was
first centrifuged at 3200 rpm for 5 min and the middle
buffy coat and part of the plasma were aspirated into
new tube where they were centrifuged at 5200 for 5 min.
The result lower middle PRP was aspirated and kept into
a sample shaker for 30 min at room temperature. Every
50 ml of blood resulted in 1.0~1.5 ml of PRP. Reagents
of thrombin and CaCl2 (1:1) (Thrombin, 1000 units, Dir-
abine® powder, Korea united pharm., Co., Korea) (CaCl2,
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100 mg/mL, Calmia® Inj., Korea united pharm., Co.,
Korea) were mixed with the PRP at 1:6 volume ratio for
creating an activated gel form. A 0.2~0.5 ml of that PRP
gel was loaded into each scaffold of MSCs+PRP+PCL-
TCP group and PRP+PCL-TCP group.
Surgical procedure
General anesthesia was induced with an intra-muscular
(IM) injection of zoletil and xylazine and maintained
with isoflurane inhalation (0.5–2%). The lower face was
shaved, swapped with iodine solution, and draped sterile.
The mandibular inferior border was incised bilaterally
within the borders of the premolar areas (Fig. 2a). Sub-
periosteal flaps were reflected, the implants sites were
prepared in the proper sequence, and half-round bony
defects were created buccally with diameter of 8 mm,
depth of 2 mm, and height of 4 mm (Fig. 2b). Thereafter,
bone-level implants (AvanaⓇ, GSII, Osstem Co., Korea)
with a length of 8.5 mm and a diameter of 4.0 mm were
inserted and the defects were filled with the customized
scaffolds (Fig. 2c, d). The stem cells were seeded into the
PCL-TCP scaffold (4.0 × 106 cells/scaffold) by a drop
Fig. 1 The PCL-TCP scaffold structure. a Tube-shape scaffold with 4-mm inner diameter, 8-mm outer diameter, 4-mm height, and 2-mm
thickness. b The scaffold was cut in half to fit the created buccal mandibular bony defects
Fig. 2 Intraoperative photographs showing the implants site drilling and placement of the MSCs-PRP-loaded PCL-TCP scaffolds. a Incision was
made along the inferior border of the mandible bilaterally within the premolar area. b Three implant sites were drilled with buccal half circle
bony defects. c, d The implants were placed and the scaffolds were placed to cover them
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down and soaking method using a micropipette and the
prepared PRP was loaded into the scaffold (0.2~0.5 ml/
scaffold). The flaps were repositioned and closed in
layers. Intra-muscular injections of oxytetracycline 3 ml
and flunixin meglumine 2 ml were given for 3 days post-
operatively.
Post-operative CT scan
Three days after the operation, a mandible CT scan was
taken to confirm the implant-scaffold stability and rule
out any post-operative complications.
Fluorochrome bone labeling
To observe the histological sequence of bone regener-
ation, three fluorochromes were intra-muscularly
injected at frequent times within 12 weeks post-
operatively. Tetracycline HCL 15 mg/kg was adminis-
tered at 3 and 11 weeks. Calcein (10 mg/kg) and alizarin
red (30 mg/kg) fluorochromes were administered at 6
and 9 weeks, respectively. The animals were sacrificed
after 12 weeks. The colorful regenerated bands were
checked using a confocal laser scanning microscope
(Olympus-Flouview300, Olympus Co., Tokyo, Japan).
The color filter ranges were red 530–560/580 nm for
red alizarin, green 494/517 nm for calcein, and yellow
525–560 nm for tetracycline.
Micro-CT bone morphogenic analysis
Using 5 implant-grafted sites, micro-CT images were ob-
tained using X-ray microtomography system (Skyscan
1072/1172, ver. 1.5, Belgium) under the settings of × 14
magnification, 80 kV/100 mA, 180° rotation, 0.90° rota-
tion step, 3.4-s exposure time, and no filtering. The ref-
erence Hounsfield unit (HU) was used to assure optimal
digital images with minimal beam hardening effects
(0.7000 HU to 0.1000 HU values in 1072 system and
0.1100 HU to 0.0030 HU in 1172 system). The digita-
lized bitmap image files were analyzed using CTAn®
software program (Skyscan Co., Belgium). The region of
interest (ROI) was drawn over the implant and scaffold
within 0.5 mm lateral to their borders. The 3-D analysis
data of the reference PCL-TCP scaffold was 255.12 mm3
in tissue volume (TV) and 240.29 mm2 in bone surface
(BS). The new bone formation capacity was analyzed
using the morphometric parameters of total tissue vol-
ume (TV, mm3), bone volume (BV, mm3), bone volume
fraction ratio (BV/TV, %), regenerative new bone surface
area (BS, mm2), bone specific surface (BS/BV, mm−1),
bone surface density (BS/TV, mm−1), and interception
surface (I.S, mm2). Three-dimensional rendered models
were obtained using the Vworks® software program
(Osstem Co., Korea).
Histomorphometric analysis
Five implant-scaffold non-decalcified bone blacks were
embedded in light curing resin (Technovit 7200 VLC+
BPO, Kulzer & Co., Germany). They were then cut lon-
gitudinally parallel to the long axis of the implants using
the Exact Cutting and Grinding Equipment (Exact Appa-
ratebau, Norderstedt, Germany) into 30-μm-thick sec-
tions. Thereafter, the samples were stained using
hematoxylin-eosin (H&E) and Masson’s trichrome (MT)
staining. New bone height (NBH, mm), new bone area
(NBA, mm2), bone-implant contact (BIC) ratio, and re-
sidual scaffold areas (RSA, mm2) were measured in the
experimental sites using Kappa Imagebase® (Kappa opto-
electronics, Germany) software.
Statistics
All data were presented as mean ± standard error.
Values of p < 0.05 were considered to be statistically sig-
nificant. Repeated measures ANOVA were used for con-
secutive comparisons among each of the groups. One
way ANOVA was used for multiple comparisons, and
post hoc tests were followed by Fisher’s protected least
significance difference (PLSD) tests for multiple pair-
wise tests using Statview® statistical software (SAS insti-
tute Inc., USA).
Results
Gross findings and post-operative CT scan
No animal died due to complications from the surgery
or due to anesthetic complications. Additionally, the
healing processes for each of the animals were unevent-
ful. A total of 30 implants were placed. Twenty-seven
implants survived and 3 implants were found loose with
no stability. Each one of these three implants belonged
to each of the three individual groups in the same side
of the used animal. No other complications like infection
or foreign-body rejection were found.
Fluorochrome bone labeling
New bone formation was found between the implant
and scaffold in the three groups. However, no separable
chronologic regenerative fluorescence bands could be
observed in the three groups (Fig. 3).
Micro-CT bone morphogenic findings
The regenerative bone volume (BV) and bone volume
fraction ratio (BV/TV) were non-significantly higher in
the PCL-TCP group and MSCs+PRP+PCL-TCP group
compared to the PRP+PCL-TCP group. The MSCs+
PRP+PCL-TCP group showed non-significant higher
bone surface (BS), bone surface density (BS/TV), and
bone specific surface (BS/BV) than the other two groups
(Fig. 4) (Table 1).
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Histomorphometric findings
The rate of scaffold degradation was slow in the PCL-
TCP group and the PRP+PCL-TCP group compared to
the MSCs+PRP+PCL-TCP group. Altogether, the
MSCs+PRP+PCL-TCP group revealed higher bone-
implant contact (BIC) ratio (p = 0.017) and new bone
height (NBH) formation (p = 0.0097) with statistically
significant difference in comparison with PCL-TCP
group. The new bone area (NBA) was largely formed
within the MSCs+PRP+Scaffold group, but with no sta-
tistically difference compared to the other groups (Fig.
5) (Table 2).
Discussion
Many resorbable and non-resorbable membranes are
used for the purpose of guided bone regeneration. Non-
resorbable materials are frequently exposed throughout
the soft tissue and need a second operation for removal
[12]. Resorbable material like collagen is considered an
outstanding biocompatible membrane. However, it lacks
rigidity and susceptible to bone dehiscence and fenestra-
tion [13]. Polyesters like poly(ε) caprolactone (PCL) are
characterized by manageability, biocompatibility,
biodegradability, and rigidity. Poly(ε) caprolactone’s
(PCL) main disadvantages are hydrophobicity, that
lowers its cells affinity, and slow degradation rate, that
may interfere with the process of bone regeneration [14,
15]. A controlled biodegradability is critical for providing
the space gradually for bone regeneration. In the present
study, β-tricalcium phosphate (TCP) was incorporated
to improve the PCL scaffold stability, osteoconductivity,
and increase the degradation rate.
Porosity is another important factor in the process of
bone regeneration. Higher porosity is expected to im-
prove bone formation by selectively increasing the diffu-
sion of nutrients, oxygen, and removal of cellular waste
products [16]. In this study, the scaffolds were designed
with 70% porosity. A previous report showed that PCL/
TCP membranes had a slightly higher elastic modulus
and promoted the proliferation of pre-osteoblasts and
inhibited fibroblast ingrowth in vitro accompanied with
significantly higher bone regeneration values than PCL
and collagen groups in vivo [17]. A better maintenance
of the alveolar contour by PCL-TCP scaffold was also
found in comparison with autogenous particulate bone
within 6 months [18].
Fig. 3 Confocal image showing the polychromic vital staining of Tetracycline HCl (3 and 11 weeks), Calcein (6 weeks), and Alizarin Red stain (9
weeks). No separable chronologic regenerative fluorescence bands could be observed in the three groups. a MSCs+PRP+PCL-TCP, b PRP+PCL-
TCP, and c PCL-TCP groups (200-μm scale bar)
Fig. 4 3D-rendered structure showing the MSCs+PRP+PCL-TCP group (a), the PRP+PCL-TCP group (b), and the PCL-TCP group (c) where more
residual scaffold remnants can be observed compared to the other groups
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In the present study, the loading of MSCs+PRP into
the PCL-TCP scaffold resulted in significant increase of
new bone formation (new bone height) and better stabil-
ity of implant(bone-implant contact ratio) compared to
the mere PCL-TCP scaffold. This indicated the import-
ant role of MSCs in the guided bone regeneration. The
results of the current study go in accordance with previ-
ous reports that showed improved bone regeneration
after loading MSCs in the scaffolds [19, 20]. The scaffold
is acting as a matrix to accommodate the cells to survive
and subsequently enhance bone formation. MSCs are
believed to enhance osteogenesis through immunosup-
pression effect. MSCs has the ability to reduce the level
of tumor necrosis factor-α (TNF-α). TNF-α is known for
its role in blockage of differentiation into osteoblasts
[21]. In the present study, umbilical cord mesenchymal
stem cells (UC- MSCs) were used. These types of stem
cells possess longer culture period and higher prolifera-
tion capacity compared to bone marrow-derived MSCs
[8]. MSCs can survive xenotransplantation without im-
mune suppression and proved to be immunosuppressive.
In one report, when pigs UC-MSCs were transplanted
into rats, they did not stimulate immune rejection and
survived for 6 weeks [22].
Platelet-rich plasma (PRP) enhanced the bone regener-
ation and degradation of the scaffold. PRP worked
through release of growth factors like vascular endothe-
lial growth factor (VEGF) which is primarily responsible
for endothelial cells proliferation in angiogenesis. Angio-
genesis or vascularization enhances bone regeneration
Table 1 Micro-CT bone morphogenic findings












5 7.52 ± 4.12 8.64 ± 5.00 616.62 ± 212.39 7.14 ± 2.64 97.18 ± 36.47
PRP+PCL-TCP 5 6.96 ± 4.10 6.41 ± 3.87 522.20 ± 171.063 4.75 ± 1.53 97.05 ± 49.92
PCL-TCP 5 8.16 ± 5.80 10.18 ± 9.30 517.77 ± 255.075 5.76 ± 3.21 87.90 ± 48.38
MSCs mesenchymal stem cells, PRP platelet-rich plasma, PCL-TCP polycaprolactone (PCL)-β-tricalcium phosphate
Fig. 5 Histomorphometric analysis. a Parameters of histomorphometric analysis; new bone height (mm, blue line), new bone area (mm2, red
polygonal area), bone-implant contact (red/yellow length ratio), and residual scaffold area (mm2, yellow polygonal area). b–d Microphotograph of
the histological structure showing new regenerative bone along the implant contact surface with degradation of the scaffold at b
MSCs+PRP+PCL-TCP, c PRP+PCL-TCP, and d PCL-TCP groups, respectively
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by accelerating the differentiation and/or maturation of
infiltrating osteoblasts and osteoblast precursor cells [7].
Conclusion
The PCL-TCP scaffold proved to be compatible for bone
regeneration in bone defects surrounding dental im-
plants. Moreover, the incorporation of MSCs and PRP
optimized the bone regeneration process with respect to
the rate of scaffold replacement, the height of the regen-
erated bone, and implant stability.
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